Printer Friendly

ANTIVIRALS: European Training Network on Antiviral Drug Development.

Total cost: EUR 3 849 087,6

EU contribution: EUR 3 849 087,6

Topic(s):

MSCA-ITN-2014-ETN - Marie Sklodowska-Curie Innovative Training Networks (ITN-ETN)

Objective: Viral infections are a major cause of disease, mortality and economic losses worldwide. Antiviral therapy is an essential instrument to control virus infections. At present, however, licensed antiviral drugs have been developed only against a limited number of viruses (e.g. HIV, HCV, influenza, herpesviruses). There is a clear and unmet need for antiviral drugs to treat infections with other important human pathogens.

Europe needs well-trained experts with multidisciplinary skills to advance the antiviral drug development field. However, few, if any, European universities or research institutes have the ability to deliver an intersectoral training programme that covers the broad spectrum of disciplines important for antiviral drug development.

The ANTIVIRALS partnership has been established to fill this gap. It consists of six outstanding European academic partners and four industrial partners (two large R&D companies, of which one is specialized in antiviral drug discovery and development, and two SMEs), and two partner organisations (incl. one SME specialised in education). All partners are leaders in their field, ensuring state-of-the-art training possibilities, and their skills are highly complementary.

ANTIVIRALS aims to introduce 15 ESRs to state-of-the-art knowledge and technology applied in antiviral drug development through both local and network-wide training activities. Individual research projects, research training workshops and intersectoral secondments will be supplemented with complementary skills courses and dissemination activities to improve career development and perspectives. The industrial partners are actively involved in the entire programme and will organize an industry-oriented conference aimed at further bridging the gap between academia and industry.

Thus, ANTIVIRALS offers talented researchers a multidisciplinary and intersectoral training programme and prepares them for a future leading role in antiviral drug development in Europe.

Coordinator

UNIVERSITEIT UTRECHT

Netherlands

EU contribution: EUR 510 748,56

Participants

ACADEMISCH ZIEKENHUIS LEIDEN

Netherlands

EU contribution: EUR 510 748,56

ALBINUSDREEF 2

2333 ZA LEIDEN

Netherlands

UNIVERSITAETSKLINIKUM HEIDELBERG

Germany

EU contribution: EUR 498 432,96

IM NEUENHEIMER FELD 672

69120 HEIDELBERG

Germany

CARDIFF UNIVERSITY

United Kingdom

EU contribution: EUR 546 575,76

NEWPORT ROAD 30-36

CF24 ODE CARDIFF

United Kingdom

UNIVERSITE D'AIX MARSEILLE

France

EU contribution: EUR 525 751,2

Boulevard Charles Livon 58

13284 Marseille

France

KATHOLIEKE UNIVERSITEIT LEUVEN

Belgium

EU contribution: EUR 250 560

Oude Markt 13

3000 LEUVEN

Belgium

ARATANA THERAPEUTICS NV

Participation ended

Belgium

EU contribution: EUR 0

AMBACHTENLAAN 1

3001 HEVERLEE

Be

Project completion date : 2019-02-28 12:00:00

Major organization : UNIVERSITEIT UTRECHT

Address : Heidelberglaan 8

3584 CS Utrecht

Country :Netherlands

Url : www.uu.nl/

Financier : EUROPEAN UNION (EU),

Financier address : European Union (EU)

Rue de la Loi 200/Wetstraat 200,

B-1049 Bruxelles/Brussels,

Belgium

Tel: 32-2-2999696, 2993085

Fax: 32-2-2961749

Url: ec.europa.eu/

[c] 2016 Al Bawaba (Albawaba.com) Provided by SyndiGate Media Inc. ( Syndigate.info ).
COPYRIGHT 2016 SyndiGate Media Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2016 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Mena Report
Geographic Code:4EUNE
Date:Jun 6, 2016
Words:471
Previous Article:DEFORM: Define the global and financial impact of research misconduct.
Next Article:SUSPOL: European Joint Doctorate in Organocatalysis and Sustainable Polymers.
Topics:

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters